Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Many trials using DNA microarrays have been reported for various human malignancies, but an efficient molecular diagnostic system has yet to be established. Here, we adopted a high throughput quantitative PCR-array system based on adaptor-tagged competitive PCR (ATAC-PCR), as a novel technique for gene expression profiling of
hepatocellular carcinoma
(
HCC
). This PCR-array contained 3,072 genes derived from three different cDNA libraries, including 298 additional known genes suspected to be involved in hepatocarcinogenesis. Using this PCR-array with 20 pairs of liver tissues (20
HCC
, 20 surrounding nontumor liver), we identified a total of 117 genes differing in expression levels in the two liver tissues. Hierarchical clustering analysis and principal component analysis with these genes revealed distinct gene expression patterns in the HBV-positive group and the HCV-positive groups. Among 117 genes, only 7 (
GPAA1
, TMEM9, FACL4, ADFP, MAWBP, PACE4, FOS) were common to both groups. In conclusion, this PCR-array analysis with an appropriate set of genes is considered useful for gene expression profiling of
HCC
, and we identified some genes which may play a common key role in hepatocarcinogenesis.
...
PMID:PCR-array gene expression profiling of hepatocellular carcinoma. 1514 62
Glycosyl-phosphatidylinositol (GPI) anchor attachment protein 1 (
GPAA1
) transcript level was frequently up-regulated in our earlier study on gene expression profile. We therefore analyzed the potential involvement of
GPAA1
in
hepatocellular carcinoma
(
HCC
) as
GPAA1
gene locates at chromosome 8q24.3 which chromosome region is frequently amplified in HCCs. In this study, we observed that
GPAA1
transcript in the HCCs (n = 93) showed a significantly higher expression level compared with their paralleled adjacent nontumor liver tissues, cirrhosis (n = 15) and normal (n = 16) liver tissues using real-time quantitative RT-PCR (p < 0.005). We also demonstrated that
GPAA1 protein
up-regulation was common in HCCs (90%, 9/10), and
GPAA1
gene was frequently amplified (73%, 11/15) using quantitative microsatellite analysis. Increased
GPAA1
expression was significantly associated with HCCs poor cellular differentiation (p = 0.011) and poor prognosis (p = 0.010). We then modulated the
GPAA1
expression level in
HCC
cells (Hep3B) by transfection experiments, which was shown to positively regulate cell adhesion ability (p = 0.004) and proliferation rate (p = 0.037). Our data revealed
GPAA1
gene amplification with overexpression of RNA and protein in
HCC
.
GPAA1
is a potential amplification target of chromosome 8q and responsible to regulate tumor cells behavior.
...
PMID:Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma. 1664 71